Investing Profile

Jonathan Leff

InvestorVC
Executive Partner at Sofinnova Investments
sofinnova.com/team/jonathan-l...Menlo Park, California
Photo of Jonathan Leff, Partner at Sofinnova Investments

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Pennsylvania Network
515 CONNECTIONS
Merck Network
62 CONNECTIONS
Roche Network
51 CONNECTIONS
Roche Network
51 CONNECTIONS
Amgen Network
42 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
Expedition Therapeutics
Series AOct 2025$170M
$280M
Co-investors: Brett Zbar (General Atlantic)
Axonis Therapeutics
Series AOct 2024$120M
$120M
Co-investors: Milad Alucozai (Entrepreneur First), Rebecca Allan (BoxOne Ventures)
Assistant Professor University of Colorado Anschutz Medical CampusPresent
Senior Director MerckPresent
Vice President - North America Medical Affairs AmgenPresent
Vice President, Global Head Inflammation Clinical Development RochePresent
Vice President RochePresent
Vice President and Chief Medical Officer Halozyme, Inc.Present
Chief Medical Officer Joanna Gerard PsychicPresent
Executive Vice President, Research and Development InterMunePresent
Senior Vice President and Chief Medical Officer Ascendis PharmaPresent
Board Member Avalyn PharmaPresent
Board Member Aerovate TherapeuticsPresent
Board Member Axonis TherapeuticsPresent
Executive Partner Sofinnova InvestmentsPresent
University of Pennsylvania B.A. Chemistry
University of Pennsylvania School of Medicine M.D. Medicine
University of Colorado Anschutz Internal Medicine Internship/Residency Internal Medicine Internship/Residency
Sign in with Google →
Sign in with Google →